Ovarian cancer patients have the highest overall expression of BRD4 and the highest rate of genetic amplifications at the BRD4 locus across the entirety of the TCGA Pan-Cancer dataset; ~11% of patients with ovarian cancer have an amplification of the region containing the BRD4 gene. This evidence concerns the gene BRD4 and cancer.